Kim G, Yoo D, Chu K, Cho E, Wi S, Song K
Animals (Basel). 2024; 14(22).
PMID: 39595289
PMC: 11591538.
DOI: 10.3390/ani14223236.
Chala W, Adamu K, Mohammed H, Deresse G, Tesfaye S, Gelaye E
Vet Med Int. 2024; 2024:6038724.
PMID: 39184947
PMC: 11343636.
DOI: 10.1155/2024/6038724.
Kushwaha A, Kumar A, Chandrasekhar S, Poulinlu G, Chand K, Muthuchelvan D
Arch Virol. 2024; 169(8):172.
PMID: 39096433
DOI: 10.1007/s00705-024-06079-3.
Berguido F, Kangethe R, Shell W, Wijewardana V, Grabherr R, Cattoli G
Viruses. 2024; 16(7).
PMID: 39066289
PMC: 11281510.
DOI: 10.3390/v16071127.
Hakobyan V, Sargsyan K, Elbakyan H, Sargsyan V, Markosyan T, Chobanyan G
Vet Sci. 2024; 11(4).
PMID: 38668431
PMC: 11053425.
DOI: 10.3390/vetsci11040164.
Cross-Protection of an Inactivated and a Live-Attenuated Lumpy Skin Disease Virus Vaccine against Sheeppox Virus Infections in Sheep.
Wolff J, Beer M, Hoffmann B
Vaccines (Basel). 2023; 11(4).
PMID: 37112675
PMC: 10143431.
DOI: 10.3390/vaccines11040763.
The emergence of novel Iranian variants in sheeppox and goatpox viral envelope proteins with remarkably altered putative binding affinities with the host receptor.
Alwan H, Torabi M, Nourani H, Al-Shuhaib M
Virus Genes. 2023; 59(3):437-448.
PMID: 36913064
DOI: 10.1007/s11262-023-01987-z.
Spatiotemporal and seasonality analysis of sheep and goat pox (SGP) disease outbreaks in Turkey between 2010 and 2019.
Sener R, Turk T
Trop Anim Health Prod. 2023; 55(2):65.
PMID: 36738334
DOI: 10.1007/s11250-023-03487-6.
Duration of Immunity Induced after Vaccination of Cattle with a Live Attenuated or Inactivated Lumpy Skin Disease Virus Vaccine.
Haegeman A, De Leeuw I, Mostin L, van Campe W, Philips W, Elharrak M
Microorganisms. 2023; 11(1).
PMID: 36677502
PMC: 9864976.
DOI: 10.3390/microorganisms11010210.
High Efficiency of Low Dose Preparations of an Inactivated Lumpy Skin Disease Virus Vaccine Candidate.
Wolff J, Beer M, Hoffmann B
Vaccines (Basel). 2022; 10(7).
PMID: 35891195
PMC: 9319008.
DOI: 10.3390/vaccines10071029.
Comparison and efficacy of two different sheep pox vaccines prepared from the Bakırköy strain against lumpy skin disease in cattle.
Uzar S, Sarac F, Gulyaz V, Enul H, Yilmaz H, Turan N
Clin Exp Vaccine Res. 2022; 11(1):1-11.
PMID: 35223661
PMC: 8844671.
DOI: 10.7774/cevr.2022.11.1.1.
Characterization of a Nigerian Lumpy Skin Disease Virus Isolate after Experimental Infection of Cattle.
Wolff J, Tuppurainen E, Adedeji A, Meseko C, Asala O, Adole J
Pathogens. 2022; 11(1).
PMID: 35055963
PMC: 8780012.
DOI: 10.3390/pathogens11010016.
Inactivation of indicator microorganisms and biological hazards by standard and/or alternative processing methods in Category 2 and 3 animal by-products and derived products to be used as organic fertilisers and/or soil improvers.
Koutsoumanis K, Allende A, Bolton D, Bover-Cid S, Chemaly M, Davies R
EFSA J. 2021; 19(12):e06932.
PMID: 34900004
PMC: 8638561.
DOI: 10.2903/j.efsa.2021.6932.
Review of sheep and goat pox disease: current updates on epidemiology, diagnosis, prevention and control measures in Ethiopia.
Zewdie G, Derese G, Getachew B, Belay H, Akalu M
Anim Dis. 2021; 1(1):28.
PMID: 34806086
PMC: 8591591.
DOI: 10.1186/s44149-021-00028-2.
Review: Vaccines and Vaccination against Lumpy Skin Disease.
Tuppurainen E, Dietze K, Wolff J, Bergmann H, Beltran-Alcrudo D, Fahrion A
Vaccines (Basel). 2021; 9(10).
PMID: 34696244
PMC: 8539040.
DOI: 10.3390/vaccines9101136.
Innate Immune Responses to Wildtype and Attenuated Sheeppox Virus Mediated Through RIG-1 Sensing in PBMC .
Chibssa T, Kangethe R, Berguido F, Settypalli T, Liu Y, Grabherr R
Front Immunol. 2021; 12:666543.
PMID: 34211465
PMC: 8240667.
DOI: 10.3389/fimmu.2021.666543.
Capripoxvirus Infections in Ruminants: A Review.
Hamdi J, Munyanduki H, Tadlaoui K, El Harrak M, Fassi Fihri O
Microorganisms. 2021; 9(5).
PMID: 33922409
PMC: 8145859.
DOI: 10.3390/microorganisms9050902.
Probe-Based Real-Time qPCR Assays for a Reliable Differentiation of Capripox Virus Species.
Wolff J, Beer M, Hoffmann B
Microorganisms. 2021; 9(4).
PMID: 33917525
PMC: 8067474.
DOI: 10.3390/microorganisms9040765.
Differentiation of Capripox Viruses by Nanopore Sequencing.
Eltom K, Althoff A, Hansen S, Bohlken-Fascher S, Yousif A, El-Sheikh H
Vaccines (Basel). 2021; 9(4).
PMID: 33917413
PMC: 8067513.
DOI: 10.3390/vaccines9040351.
Development of a Safe and Highly Efficient Inactivated Vaccine Candidate against Lumpy Skin Disease Virus.
Wolff J, Moritz T, Schlottau K, Hoffmann D, Beer M, Hoffmann B
Vaccines (Basel). 2020; 9(1).
PMID: 33374808
PMC: 7823700.
DOI: 10.3390/vaccines9010004.